AI being used to analyse thousands of Māori stone artefacts languishing in storerooms around NZ stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
MBIE grant expected to generate at least four new spinouts and $500m benefits.
Imagine if your doctor could generate a realistic digital model of your body using data from medical tests and sensors, and virtually trial different drug therapies to predict which one
Choose your best value subscription option here.
Already have an account? Login Related news
Bioengineering Institute gets $15m to help build a digital you nbr.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbr.co.nz Daily Mail and Mail on Sunday newspapers.
Friday, 16 April 2021, 6:05 am
Alimetry, a digital healthcare and diagnostic devices
start-up, announced today that it has achieved CE Mark for
its first product, a pioneering medical device for enabling
diagnosis of gastric diseases.
The new wearable
product, called Gastric Alimetry, is positioned to transform
the diagnostic pathway for millions of patients worldwide
suffering from diseases such as functional dyspepsia,
gastroparesis and chronic nausea and vomiting. Gastric
symptoms are extremely prevalent and impart a vast burden,
affecting around 10% of the global population. The Gastric
Alimetry device collects data by non-invasively sensing the
activity of the stomach from the body surface. The data is
ABI’s ideas generator has spawned 25 spinouts and has new focus on telehealth.
Joining the global ballet of Covid-pivots, IMeasureU, a company that makes wearable sensing technology for monitoring muscle workloads in sport, is now looking at uses in orthopaedics in the wake of stalled sporting events.
IMeasureU’s technology, which precisely quantifies body movement and workload metrics, could be used to monitor mobility of patients following joint replacements, helping rehabilitation, explained Professor Thor Besier from the University of Auckland’s Auckland Bioengineering Institute (ABI), whose research created the technology and who co-founded the original startup with fellow researcher Mark Finch.